Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Wednesday Oct 16, 2024
Wednesday Oct 16, 2024
touchMDT for touchONCOLOGY
Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations.
The multidisciplinary team
- Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
- Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA
- Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany
This touchPODCAST is for HCPs outside the UK.
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
www.touchONCOLOGY.com
Wednesday Oct 16, 2024
Wednesday Oct 16, 2024
touchMDT for touchRESPIRATORY
Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations.
The multidisciplinary team
- Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
- Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA
- Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany
This touchPODCAST is for HCPs outside the UK.
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
www.touchRESPIRATORY.com
Wednesday Oct 16, 2024
Wednesday Oct 16, 2024
touchMDT for touchRESPIRATORY
Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations.
The multidisciplinary team
- Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
- Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA
- Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany
This touchPODCAST is for HCPs outside the UK.
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
www.touchRESPIRATORY.com
Tuesday Oct 15, 2024
Tuesday Oct 15, 2024
touchFOCUS for touchONCOLOGY
Listen to Dr Jennifer Carlisle, an expert in lung cancer, as she answers a series of questions on the targeted perioperative treatment strategies and best practices for patients with resectable and unresectable early-stage EGFR-mutant NSCLC. She also discusses how the evolving treatment landscape impacts biomarker testing and the importance of multidisciplinary care for optimizing outcomes in these patients.
The expert
Dr Jennifer Carlisle, Winship Cancer Institute of Emory University, Atlanta, GA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchoncology.org/EGFR-mutant-treatment-options-early-NSCLC
Monday Oct 07, 2024
Monday Oct 07, 2024
touchCONGRESS for touchONCOLOGY
Listen to multiple myeloma expert Prof. María-Victoria Mateos review key data for BCMA-targeting agents in the treatment of multiple myeloma presented at the international Controversies in Multiple Myeloma (COMy) and European Hematology Association (EHA) 2024 congresses. Prof. Mateos is then joined by fellow experts Dr Rakesh Popat and Prof. Evangelos Terpos to discuss how these data may apply in clinical practice.
Overview
- Data reviews with Prof. Mateos,
- Expert panel discussions with Prof. Mateos, Dr Popat and Prof. Terpos on the themes below
Clinical themes
- Approved indications for BCMA-targeting agents,
- New approaches to the use of existing BCMA-targeting agents,
- Emerging BCMA-targeting agents
The internationally renowned multiple myeloma expert faculty
- Prof. María-Victoria Mateos: Salamanca, Spain,
- Dr Rakesh Popat: London, UK,
- Prof. Evangelos Terpos: Athens, Greece
This touchPODCAST is for HCPs outside of the USA and UK only.
This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website: https://touchoncologyime.org/bcma-mm-comy-eha-2024
Monday Oct 07, 2024
Monday Oct 07, 2024
touchCONGRESS for touchHAEMATOLOGY
Listen to multiple myeloma expert Prof. María-Victoria Mateos review key data for BCMA-targeting agents in the treatment of multiple myeloma presented at the international Controversies in Multiple Myeloma (COMy) and European Hematology Association (EHA) 2024 congresses. Prof. Mateos is then joined by fellow experts Dr Rakesh Popat and Prof. Evangelos Terpos to discuss how these data may apply in clinical practice.
Overview
- Data reviews with Prof. Mateos,
- Expert panel discussions with Prof. Mateos, Dr Popat and Prof. Terpos on the themes below
Clinical themes
- Approved indications for BCMA-targeting agents,
- New approaches to the use of existing BCMA-targeting agents,
- Emerging BCMA-targeting agents
The internationally renowned multiple myeloma expert faculty
- Prof. María-Victoria Mateos: Salamanca, Spain,
- Dr Rakesh Popat: London, UK,
- Prof. Evangelos Terpos: Athens, Greece
This touchPODCAST is for HCPs outside of the USA and UK only.
This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchhaematologyime.org/bcma-mm-comy-eha-2024
Monday Oct 07, 2024
Monday Oct 07, 2024
touchEXPERT OPINIONS for touchOPHTHALMOLOGY
Listen to leading experts describe the pathophysiology of open-angle glaucoma and discuss how it is targeted by current and emerging treatment options, while providing insights on how different agents and combinations are used in practice.
The experts
- Angelo P Tanna, MD - Northwestern University Feinberg School of Medicine, Chicago, IL, USA
- Courtney E Bovee, MD - Bovee Eye, Tampa Bay, FL, USA
- Joseph F Panarelli, MD - NYU Langone Eye Center, New York, NY, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Alcon Vision, LLC and is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchOPHTHALMOLOGY.com/
Monday Sep 30, 2024
Monday Sep 30, 2024
touchIN CONVERSATION for touchIMMUNOLOGY
Listen to Prof. Diamant Thaçi in conversation with Dr Benjamin Ungar. They respond to questions submitted by the HCP audience and provide their expert insights regarding managing moderate–severe atopic dermatitis (AD) in children and adolescents, including assessing the severity of AD, selecting systemic therapy, and managing the potential side effects of systemic treatment.
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals and is jointly provided by USF Health and touchIME.
For further information visit our website: touchimmunology.com
Monday Sep 30, 2024
Monday Sep 30, 2024
touchIN CONVERSATION for touchDERMATOLOGY
Listen to Prof. Diamant Thaçi in conversation with Dr Benjamin Ungar. They respond to questions submitted by the HCP audience and provide their expert insights regarding managing moderate–severe atopic dermatitis (AD) in children and adolescents, including assessing the severity of AD, selecting systemic therapy, and managing the potential side effects of systemic treatment.
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals and is jointly provided by USF Health and touchIME.
For further information visit our website: touchderma.com
Thursday Sep 26, 2024
Thursday Sep 26, 2024
touchFOCUS for touchONCOLOGY
Listen to Prof. Barbara Burtness as she answers a series of questions focused on the evolving role of immune checkpoint inhibitors in the first- and subsequent-line settings for recurrent/metastatic nasopharyngeal carcinoma.
The expert
Prof. Barbara Burtness, Yale School of Medicine, New Haven, CT, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Coherus BioSciences. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/touchfocus_evolving-role-of-icis-in-rm-npc/